Affinity Asset Advisors’s Karyopharm Therapeutics KPTI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Hold	0	–	–	–	96
2023 Q2	–	Sell	-30,732	Closed	-$1.79M	–	71
2023 Q1	$1.79M	Sell	30,732 -13,352	-30%	-$779K	0.59%	38
2022 Q4	$2.25M	Buy	+44,084	New	+$2.25M	0.88%	29